Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALLDAY E. J., BARNES J. Toxic effects of diaminodiphenylsulphone in treatment of leprosy. Lancet. 1951 Aug 4;2(6675):205–206. doi: 10.1016/s0140-6736(51)91443-2. [DOI] [PubMed] [Google Scholar]
- Degowin R. L., Eppes R. B., Powell R. D., Carson P. E. The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bull World Health Organ. 1966;35(2):165–179. [PMC free article] [PubMed] [Google Scholar]
- Frey H. M., Gershon A. A., Borkowsky W., Bullock W. E. Fatal reaction to dapsone during treatment of leprosy. Ann Intern Med. 1981 Jun;94(6):777–779. doi: 10.7326/0003-4819-94-6-777. [DOI] [PubMed] [Google Scholar]
- Ishak K. G., Zimmerman H. J. Drug-induced and toxic granulomatous hepatitis. Baillieres Clin Gastroenterol. 1988 Apr;2(2):463–480. doi: 10.1016/0950-3528(88)90012-7. [DOI] [PubMed] [Google Scholar]
- JELLIFFE D. B. Toxic hepatitis caused by diaminodiphenylsulphone. Lancet. 1951 Jun 23;1(6669):1343–1344. doi: 10.1016/s0140-6736(51)92794-8. [DOI] [PubMed] [Google Scholar]
- Johnson D. A., Cattau E. L., Jr, Kuritsky J. N., Zimmerman H. J. Liver involvement in the sulfone syndrome. Arch Intern Med. 1986 May;146(5):875–877. [PubMed] [Google Scholar]
- Kemper C. A., Tucker R. M., Lang O. S., Kessinger J. M., Greene S. I., Deresinski S. C., Stevens D. A. Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex. AIDS. 1990 Nov;4(11):1145–1148. doi: 10.1097/00002030-199011000-00015. [DOI] [PubMed] [Google Scholar]
- Kromann N. P., Vilhelmsen R., Stahl D. The dapsone syndrome. Arch Dermatol. 1982 Jul;118(7):531–532. [PubMed] [Google Scholar]
- LEIKER D. L. The mononucleosis syndrome in leprosy patients treated with sulfones. Int J Lepr. 1956 Oct-Dec;24(4 Pt 1):402–405. [PubMed] [Google Scholar]
- LOWE J., SMITH M. The chemotherapy of leprosy in Nigeria; with an appendix on glandular fever and exfoliative dermatitis precipitated by sulfones. Int J Lepr. 1949 Jul-Sep;17(3):181–195. [PubMed] [Google Scholar]
- Lawrence W. A., Olsen H. W., Nickles D. J. Dapsone hepatitis. Arch Intern Med. 1987 Jan;147(1):175–175. [PubMed] [Google Scholar]
- Medina I., Mills J., Leoung G., Hopewell P. C., Lee B., Modin G., Benowitz N., Wofsy C. B. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med. 1990 Sep 20;323(12):776–782. doi: 10.1056/NEJM199009203231202. [DOI] [PubMed] [Google Scholar]
- Millikan L. E., Harrell E. R. Drug reactions to the sulfones. Arch Dermatol. 1970 Aug;102(2):220–224. [PubMed] [Google Scholar]
- Montgomery A. B. Prophylaxis of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus type 1. Semin Respir Infect. 1989 Dec;4(4):311–317. [PubMed] [Google Scholar]
- Safrin S., Sattler F. R., Lee B. L., Young T., Bill R., Boylan C. T., Mills J. Dapsone as a single agent is suboptimal therapy for Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr. 1991;4(3):244–249. [PubMed] [Google Scholar]
- Schaffner F. The liver in HIV infection. Prog Liver Dis. 1990;9:505–522. [PubMed] [Google Scholar]
- Tomecki K. J., Catalano C. J. Dapsone hypersensitivity. The sulfone syndrome revisited. Arch Dermatol. 1981 Jan;117(1):38–39. doi: 10.1001/archderm.117.1.38. [DOI] [PubMed] [Google Scholar]
- Wille R. C., Morrow J. D. Case report: dapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider. Am J Med Sci. 1988 Oct;296(4):270–271. doi: 10.1016/s0002-9629(15)40859-6. [DOI] [PubMed] [Google Scholar]